You can find the annual or quarterly income statement of C4 Therapeutics Inc here for insights into the performance and operational efficiency of C4 Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

Total revenue

112.79%11.02M

-26.90%11.23M

-46.17%6.46M

138.17%7.24M

58.75%5.18M

38.75%15.36M

350.68%12.01M

-19.15%3.04M

14.26%3.26M

63.93%11.07M

-80.74%2.66M

-50.89%3.76M

-85.79%2.85M

-20.54%6.75M

41.44%13.83M

3.07%7.65M

143.02%20.08M

0.63%8.50M

--9.78M

--7.43M

--8.26M

--8.45M

Revenue

112.79%11.02M

-26.90%11.23M

-46.17%6.46M

138.17%7.24M

58.75%5.18M

38.75%15.36M

350.68%12.01M

-19.15%3.04M

14.26%3.26M

63.93%11.07M

-80.74%2.66M

-50.89%3.76M

-85.79%2.85M

-20.54%6.75M

41.44%13.83M

3.07%7.65M

143.02%20.08M

0.63%8.50M

--9.78M

--7.43M

--8.26M

--8.45M

Operating expenses

-20.34%34.16M

-19.94%34.91M

4.53%34.96M

10.91%36.40M

5.40%42.89M

12.16%43.61M

-16.86%33.45M

-17.92%32.82M

-1.12%40.69M

-0.92%38.88M

-2.39%40.23M

2.47%39.99M

16.45%41.15M

19.81%39.24M

29.22%41.22M

39.69%39.02M

30.07%35.33M

22.23%32.75M

--31.90M

--27.93M

--27.16M

--26.80M

R&D expenses

-23.16%24.98M

-18.37%25.99M

10.29%26.20M

20.14%27.07M

6.98%32.51M

12.32%31.84M

-20.63%23.75M

-22.41%22.53M

-0.85%30.39M

-4.44%28.35M

-4.46%29.93M

10.83%29.04M

15.45%30.65M

22.06%29.66M

34.51%31.32M

27.66%26.20M

29.94%26.55M

4.14%24.30M

--23.29M

--20.53M

--20.43M

--23.34M

Depreciation, depletion, and amortization

-10.83%428.00K

4.07%460.00K

37.28%615.00K

1.79%456.00K

11.63%480.00K

-1.12%442.00K

-2.18%448.00K

-17.80%448.00K

-17.47%430.00K

7.71%447.00K

5.29%458.00K

78.69%545.00K

61.30%521.00K

25.76%415.00K

12.11%435.00K

-32.37%305.00K

-11.51%323.00K

-45.00%330.00K

--388.00K

--451.00K

--365.00K

--600.00K

Operating profit

38.62%-23.14M

16.16%-23.68M

-32.92%-28.50M

2.08%-29.16M

-0.75%-37.71M

-1.57%-28.24M

42.92%-21.44M

17.79%-29.78M

2.26%-37.43M

14.41%-27.81M

-37.19%-37.57M

-15.49%-36.23M

-151.02%-38.29M

-33.95%-32.49M

-23.82%-27.38M

-52.95%-31.37M

19.30%-15.26M

-32.18%-24.25M

---22.12M

---20.51M

---18.90M

---18.35M

Net non-operating interest income (expenses)

Non-operating interest income

-14.91%2.78M

-37.23%2.25M

-33.41%2.48M

-26.33%2.84M

10.75%3.27M

39.66%3.58M

65.89%3.73M

87.83%3.86M

72.62%2.95M

136.35%2.56M

343.87%2.25M

644.20%2.05M

1156.62%1.71M

885.45%1.08M

633.33%506.00K

283.33%276.00K

-78.14%136.00K

--110.00K

--69.00K

--72.00K

--622.00K

----

Non-operating interest expense

----

--0.00

-100.00%0.00

-69.86%167.00K

12.36%600.00K

14.99%606.00K

11.50%601.00K

2.78%554.00K

0.19%534.00K

-1.31%527.00K

-49.10%539.00K

--539.00K

--533.00K

--534.00K

--1.06M

----

Special income (expenses)

--0.00

---10.73M

--0.00

100.00%0.00

--0.00

100.00%0.00

--0.00

---2.44M

--0.00

---621.00K

----

100.00%0.00

----

---2.54M

---3.14M

Other non-operating income (expenses)

--3.00K

----

---44.00K

---160.00K

Income before tax

40.87%-20.36M

-30.41%-32.17M

-46.87%-26.02M

7.19%-26.32M

0.10%-34.44M

5.25%-24.67M

50.68%-17.72M

18.46%-28.36M

7.28%-34.48M

18.54%-26.03M

-31.04%-35.92M

-9.99%-34.78M

-137.48%-37.19M

-29.47%-31.96M

-21.40%-27.41M

-50.78%-31.62M

28.56%-15.66M

-12.19%-24.68M

---22.58M

---20.97M

---21.92M

---22.00M

Income tax

-7.63%121.00K

--0.00

-52.71%131.00K

-100.00%0.00

----

--277.00K

--1.00M

----

--0.00

100.00%0.00

--0.00

---124.00K

---167.00K

Income after tax

40.75%-20.49M

-30.41%-32.17M

-46.87%-26.02M

7.19%-26.32M

0.52%-34.57M

8.77%-24.67M

50.68%-17.72M

18.46%-28.36M

6.54%-34.75M

15.40%-27.04M

-31.04%-35.92M

-9.99%-34.78M

-137.48%-37.19M

-29.47%-31.96M

-21.40%-27.41M

-50.78%-31.62M

28.16%-15.66M

-13.04%-24.68M

---22.58M

---20.97M

---21.80M

---21.84M

Net income from continuous operations

40.75%-20.49M

-30.41%-32.17M

-46.87%-26.02M

7.19%-26.32M

0.52%-34.57M

8.77%-24.67M

50.68%-17.72M

18.46%-28.36M

6.54%-34.75M

15.40%-27.04M

-31.04%-35.92M

-9.99%-34.78M

-137.48%-37.19M

-29.47%-31.96M

-21.40%-27.41M

-50.78%-31.62M

28.16%-15.66M

-13.04%-24.68M

---22.58M

---20.97M

---21.80M

---21.84M

Net income attributable to controlling interests

40.75%-20.49M

-30.41%-32.17M

-46.87%-26.02M

7.19%-26.32M

0.52%-34.57M

8.77%-24.67M

50.68%-17.72M

18.46%-28.36M

6.54%-34.75M

15.40%-27.04M

-31.04%-35.92M

-9.99%-34.78M

-137.48%-37.19M

-29.47%-31.96M

-21.40%-27.41M

-50.78%-31.62M

-36.97%-15.66M

8.74%-24.68M

---22.58M

---20.97M

---11.43M

---27.05M

Preferred share dividend

----

--0.00

-100.00%0.00

--0.00

----

--5.21M

Net income attributable to common shareholders

40.75%-20.49M

-30.41%-32.17M

-46.87%-26.02M

7.19%-26.32M

0.52%-34.57M

8.77%-24.67M

50.68%-17.72M

18.46%-28.36M

6.54%-34.75M

15.40%-27.04M

-31.04%-35.92M

-9.99%-34.78M

-137.48%-37.19M

-29.47%-31.96M

-21.40%-27.41M

-50.78%-31.62M

-36.97%-15.66M

8.74%-24.68M

---22.58M

---20.97M

---11.43M

---27.05M

Basic earnings per share

64.29%-0.17

-25.13%-0.44

-42.33%-0.37

10.33%-0.37

27.80%-0.49

35.52%-0.35

64.84%-0.26

41.57%-0.41

10.71%-0.68

15.90%-0.55

-30.40%-0.73

-9.33%-0.71

-136.09%-0.76

-28.33%-0.65

-9.05%-0.56

-33.30%-0.65

-21.16%-0.32

21.81%-0.51

---0.51

---0.49

---0.27

---0.65

Diluted earnings per share

64.29%-0.17

-25.13%-0.44

-42.33%-0.37

10.33%-0.37

27.80%-0.49

35.52%-0.35

64.84%-0.26

41.57%-0.41

10.71%-0.68

15.90%-0.55

-30.40%-0.73

-9.33%-0.71

-136.09%-0.76

-28.33%-0.65

-9.05%-0.56

-33.30%-0.65

-21.16%-0.32

21.81%-0.51

---0.51

---0.49

---0.27

---0.65

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

